Barclays »

BioAtla shares owned by Barclays

Quarter-by-quarter ownership of BioAtla (BCAB) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in BioAtla

Tip: Access up to 7 years of quarterly data

All positions including BioAtla held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioAtla by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $417 101 4.14

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding BioAtla

Millennium Management
Lido Advisors
Stonepine Capital Management
Acadian Asset Management
Hrt Financial
Geode Capital Management
Deutsche Bank Aktiengesellschaft
BlackRock
Vanguard Capital Management
UBS Group
Vanguard Fiduciary Trust
Tower Research Capital
Forum Finance Group
SBI Securities
Twin Lakes Capital Management

View all funds holding BioAtla